Orphanet Journal of Rare Diseases operates a single-blind peer-review system, where the reviewers are aware of the names and affiliations of the authors, but the reviewer reports provided to authors are anonymous.
The benefit of single-blind peer review is that it is the traditional model of peer review that many reviewers are comfortable with, and it facilitates a dispassionate critique of a manuscript.
Publication of research articles by Orphanet Journal of Rare Diseases is dependent primarily on their scientific validity and coherence as judged by our external expert editors and/or peer reviewers, who will also assess whether the writing is comprehensible and whether the work represents a useful contribution to the field. Submitted manuscripts will be screened for relevance and style. Manuscripts deemed suitable for review will be sent to at least two experts, and possibly a statistical reviewer, to determine originality, scientific merit, and significance to the field.
Orphanet Journal of Rare Diseases considers the following types of article: Brief report, Methodology, Research, Software, and Workflow. For more specific information, please take a look at our Submission Guidelines.
Orphanet Journal of Rare Diseases is the official journal of Orphanet, the portal for rare diseases and orphan drugs.
2018 Journal Metrics
95 days to first decision for reviewed manuscripts only
72 days to first decision for all manuscripts
147 days from submission to acceptance
23 days from acceptance to publication
1029 Altmetric mentions